Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.
Bialucha, C.U., Collins, S.D., Li, X., Saxena, P., Zhang, X., Durr, C., Lafont, B., Prieur, P., Shim, Y., Mosher, R., Lee, D., Ostrom, L., Hu, T., Bilic, S., Rajlic, I.L., Capka, V., Jiang, W., Wagner, J.P., Elliott, G., Veloso, A., Piel, J.C., Flaherty, M.M., Mansfield, K.G., Meseck, E.K., Rubic-Schneider, T., London, A.S., Tschantz, W.R., Kurz, M., Nguyen, D., Bourret, A., Meyer, M.J., Faris, J.E., Janatpour, M.J., Chan, V.W., Yoder, N.C., Catcott, K.C., McShea, M.A., Sun, X., Gao, H., Williams, J., Hofmann, F., Engelman, J.A., Ettenberg, S.A., Sellers, W.R., Lees, E.
Cancer Discov